News

Press releaseSeptember2024
Laurentis signs MOU with Colibri to pursue isotopes irradiation services
Both are to explore use of Colibri's target technology and Laurentis' TDS technology (developed with BWXT) to irradiate isotopes that would allow to reach unmatched yields of high-quality medical isotopes.
NewsFebruary2024
Colibri receives patent (U.S. Pat. No. 11,894,156)
Novelle target technology that allows to irradiate and process Yb-176 targets with masses of 2 to 50 gram.
NewsNovember2023
Morpho tests the Kalupso module at Colibri’s facility
Colibri supports Morpho in testing the first standard unit of KaLupso, a unique fully automatic Lu-177 processing equipment, at their facility in Lubbock. Ongoing.